obesity drug glp-1 news today The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs With FDA approval of Wegovy

"Efficacy and Safety of Retatrutide in Adults with Obesity." NEJM

Patient-specific factors should be considered when assessing the risks of these patients for delayed gastric emptying and pulmonary aspiration

For example, in clinical trials of Wegovy, hair loss was reported in 2.5% of Wegovy-treated adult patients vs 1.0% of placebo-treated adult patients

doi: 10.1002/oby.21718

The healthcare professional will provide guidance on the most effective and safe approach to achieving your weight management goals based on your individual needs and circumstances

2124 Collectively, these findings underscore the critical role of nutrient-mediated regulation of GLP-1, with implications for chronic lifestyle-associated diseases and overall metabolic health